(3.235.45.196)
Users online: 1602    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 5
First page : ( 2327) Last page : ( 2332)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00387.1

Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on lipid profile in vitamin D deficient/insufficient polycystic ovary syndrome patients: A Randomized, Placebo-Controlled Clinical Trial

Kadoura Sally1,*, Alhalabi Marwan2,3, Nattouf Abdul Hakim1

1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syria

2Department of Embryology and Reproductive Medicine, Faculty of Medicine, Damascus University, Damascus, Syria

3Assisted Reproduction Unit, Orient Hospital, Damascus, Syria

*Corresponding Author E-mail: sally.kadoura@damascusuniversity.edu.sy

Online published on 8 August, 2019.

Abstract

Objective

This study aims to investigate the impact of combining calcium and vitamin D supplements with metformin on lipid profile in vitamin D deficient/insufficient polycystic ovary syndrome (PCOS) women.

Study design

A randomized, placebo-controlled clinical trial.

Setting

Damascus University of Obstetrics and Gynecology Hospital and Orient Hospital, in Damascus, Syria.

Materials and methods

Forty PCOS women with 25-hydroxyvitamin D < 30 ng/mL were randomly assigned to take either metformin (1500 mg/daily) plus placebo or metformin (1500 mg/daily) plus calcium (1000 mg/daily) and vitamin D3 (6000 IU/daily) orally for 8 weeks. Fasting serum levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), triglyceride (TG) and non-HDL cholesterol (non-HDL) were detected at the baseline and after 8 weeks of intervention.

Results

Of all participants, thirty-four completed the study. After 8 weeks of intervention, calcium and vitamin D levels increased significantly in the supplementation group, but no significant changes in the lipid profile were noticed in both groups.

Conclusions

Adding calcium and vitamin D to metformin therapy had no superior effect on improving lipid profile in vitamin D deficient/insufficient subjects with PCOS. The Clinical Trial Registration Number is NCT03792984.

Top

Keywords

Polycystic Ovary Syndrome, Lipid Profile, Calcium, Vitamin D, Metformin.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
435,079,069 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.